US President Donald Trump has shared an AI-generated video on Truth Social, depicting himself as a doctor offering a 'treatment plan' for T...

Nestle is set to eliminate all artificial food colorings globally by the end of 2026, a significant move by the major food producer. This i...

Despite rising obesity and affordable generic GLP-1 drugs, India lags in adoption. Nithin Kamath highlights patient retention challenges wi...

Prime Minister Keir Starmer has unveiled a £15 billion Defence Investment Plan, aiming to bolster Britain's military for future conflicts. ...

India's widening water deficit could create an infrastructure investment opportunity worth over Rs 20 lakh crore over the next decade, acco...

Snoring, often dismissed as a mere annoyance, can signal underlying health issues like sleep apnea. The sound arises from obstructed breath...

Recent incidents of violence and protests have heightened racial tensions in Britain, leading some ethnic minorities to feel increasingly u...

The UK government is set to invest a noteworthy £580 million into its Defence Science and Technology Laboratory, aligning with its Defence ...

Nithin Kamath questions India's slow adoption of affordable GLP-1 weight-loss drugs, despite rising obesity. He points to challenges like l...

Britain is set to introduce safe, legal pathways for refugees, allowing community groups and employers to sponsor arrivals. Simultaneously,...

Initial excitement for India's generic weight-loss drugs is fading. Domestic manufacturers are lowering sales targets due to slower-than-ex...

Keir Starmer's Labour government, which secured a landslide victory, prioritized strengthening ties with India, culminating in the India-UK...

Pfizer's finance chief Dave Denton is leaving on August 15. Cecile Guegan will be the interim chief financial officer. Denton's departure r...

Jeremy Clarkson has revealed his diagnosis with an aggressive form of prostate cancer, detected last summer and treated with surgery. Prost...

Rising demand for weight-loss drugs, cosmetic procedures and wellness treatments is creating a growing out-of-pocket healthcare expense cat...

India's market for cheaper anti-obesity drugs has surged tenfold. While demand is high, especially among those with diabetes, concerns abou...

Britain's medicine regulator has approved Novo Nordisk's weight-loss pill. This makes the UK the first European market for the oral treatme...